Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Test-dose melphalan pharmacokinetics in multiple myeloma undergoing autologous stem cell transplantation
ACTRN12613000487718Phase 4Completed
- Sponsor
- The Children's Hospital at Westmead
- Start
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of melphalan in multiple myeloma (MM), sponsored by The Children's Hospital at Westmead. Primary endpoint: Feasibility of real-time melphalan pharmacokinetics and therapeutic drug monitoring in a multi-centre setting. Started Apr 2013; status: completed.
02
Drugs
melphalan
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on ACTRN12613000487718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613000487718.